February 20, 2020
Kenneth Rosenthal, head of the viral vaccines division at the McMaster Immunology Research Centre, talks about how research teams across the globe are searching for a COVID-19 vaccine.
We believe in the free flow of information. This work is licensed under a Creative Commons Attribution-No
Derivs 2.5 Canada (CC BY-ND 2.5 CA), so you can republish our articles for free, online or
in print.All republished articles must be attributed in the following way and contain links to both the site and original article: “This article was first published on Brighter World. Read the original article.”
The Communications and Public Affairs Office is staffed from 8:30 a.m. to 4:30 p.m. Monday to
Friday.
The University has a broadcast quality television studio to facilitate live and pre-recorded interviews with media. Learn more about our experts.
Pfizer is investing $500,000 in McMaster's Global Nexus to support emerging vaccinology scholars from equity-deserving groups and students conducting vaccine research that will help populations that are especially vulnerable to infectious disease.
